Compagnie Lombard Odier SCmA’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16
Closed -$3.66K 490
2024
Q4
$3.66K Hold
16
﹤0.01% 424
2024
Q3
$3.91K Hold
16
﹤0.01% 423
2024
Q2
$3.06K Hold
16
﹤0.01% 419
2024
Q1
$3.17K Hold
16
﹤0.01% 446
2023
Q4
$2.75K Hold
16
﹤0.01% 523
2023
Q3
$2.37K Hold
16
﹤0.01% 559
2023
Q2
$3.5K Hold
16
﹤0.01% 532
2023
Q1
$3.5K Hold
16
﹤0.01% 579
2022
Q4
$3K Hold
16
﹤0.01% 644
2022
Q3
$3K Hold
16
﹤0.01% 606
2022
Q2
$3K Hold
16
﹤0.01% 578
2022
Q1
$4K Hold
16
﹤0.01% 575
2021
Q4
$4K Hold
16
﹤0.01% 654
2021
Q3
$4K Hold
16
﹤0.01% 624
2021
Q2
$4K Hold
16
﹤0.01% 615
2021
Q1
$3K Hold
16
﹤0.01% 640
2020
Q4
$3K Buy
+16
New +$3.19K ﹤0.01% 553
2014
Q3
Sell
-2,477
Closed -$125K 889
2014
Q2
$125K Hold
2,477
0.01% 632
2014
Q1
$111K Hold
2,477
﹤0.01% 636
2013
Q4
$117K Buy
+2,477
New +$125K ﹤0.01% 632

Other funds holding RMD

Compagnie Lombard Odier SCmA's RMD Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of ResMed (RMD) in Q1 2025, closing a stake of 16 shares — an estimated $3.66K sold.

Compagnie Lombard Odier SCmA first reported a position in RMD in Q4 2013 and held it in 20 quarters. The position peaked at $125K in Q2 2014. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Compagnie Lombard Odier SCmA reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 16 ResMed shares in Q1 2025, an estimated $3.66K.
  • Compagnie Lombard Odier SCmA first reported a position in ResMed in Q4 2013 and held it in 20 quarters.
  • Compagnie Lombard Odier SCmA's ResMed position peaked at $125K in Q2 2014.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.